↓ Skip to main content

Cochrane Database of Systematic Reviews

Quetiapine versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
2 blogs
twitter
35 tweeters
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
276 Mendeley
citeulike
1 CiteULike
Title
Quetiapine versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd006625.pub3
Pubmed ID
Authors

Laila Asmal, Srnka J Flegar, Jikun Wang, Christine Rummel-Kluge, Katja Komossa, Stefan Leucht

Abstract

In many countries, second-generation ('atypical') antipsychotic drugs have become the first-line drug treatment for people with schizophrenia. It is not clear how the effects of the various second-generation antipsychotic drugs differ.

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 276 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Chile 1 <1%
Uruguay 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Japan 1 <1%
Unknown 269 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 46 17%
Researcher 42 15%
Student > Bachelor 35 13%
Student > Ph. D. Student 25 9%
Student > Postgraduate 24 9%
Other 60 22%
Unknown 44 16%
Readers by discipline Count As %
Medicine and Dentistry 104 38%
Psychology 26 9%
Nursing and Health Professions 21 8%
Pharmacology, Toxicology and Pharmaceutical Science 20 7%
Neuroscience 16 6%
Other 34 12%
Unknown 55 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2017.
All research outputs
#700,004
of 17,781,901 outputs
Outputs from Cochrane database of systematic reviews
#1,739
of 11,761 outputs
Outputs of similar age
#10,212
of 273,884 outputs
Outputs of similar age from Cochrane database of systematic reviews
#18
of 116 outputs
Altmetric has tracked 17,781,901 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,761 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,884 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.